Meng Guo

1.0k total citations
32 papers, 704 citations indexed

About

Meng Guo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Meng Guo has authored 32 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Oncology. Recurrent topics in Meng Guo's work include Immune Cell Function and Interaction (7 papers), MicroRNA in disease regulation (4 papers) and CAR-T cell therapy research (4 papers). Meng Guo is often cited by papers focused on Immune Cell Function and Interaction (7 papers), MicroRNA in disease regulation (4 papers) and CAR-T cell therapy research (4 papers). Meng Guo collaborates with scholars based in China, India and Canada. Meng Guo's co-authors include Quanxing Wang, Jianming Zheng, Yanfang Liu, Hailing Zhang, Weifeng Jiang, Jun Gu, Li Zhou, Guoshan Ding, Hong‐Wei Tan and Wenyuan Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Biochemical and Biophysical Research Communications.

In The Last Decade

Meng Guo

32 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Guo China 16 315 156 137 115 107 32 704
Zhaoya Liu China 13 306 1.0× 203 1.3× 104 0.8× 108 0.9× 44 0.4× 26 656
Sen Wei China 14 382 1.2× 141 0.9× 57 0.4× 40 0.3× 61 0.6× 26 663
Fengwei Li China 13 280 0.9× 211 1.4× 55 0.4× 21 0.2× 46 0.4× 24 514
Elżbieta Urasińska Poland 14 234 0.7× 68 0.4× 60 0.4× 32 0.3× 125 1.2× 57 665
Jilin Li China 17 453 1.4× 241 1.5× 131 1.0× 26 0.2× 234 2.2× 51 840
Shunji Nakatsuji Japan 14 205 0.7× 48 0.3× 79 0.6× 34 0.3× 60 0.6× 32 699
Qun Zhang China 14 298 0.9× 206 1.3× 91 0.7× 12 0.1× 109 1.0× 57 736
Jianlin Chen China 16 443 1.4× 163 1.0× 211 1.5× 27 0.2× 272 2.5× 69 1.1k
Bo Jin China 15 248 0.8× 65 0.4× 69 0.5× 165 1.4× 43 0.4× 43 652

Countries citing papers authored by Meng Guo

Since Specialization
Citations

This map shows the geographic impact of Meng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Guo more than expected).

Fields of papers citing papers by Meng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Guo. The network helps show where Meng Guo may publish in the future.

Co-authorship network of co-authors of Meng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Guo. A scholar is included among the top collaborators of Meng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Guo. Meng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Jianhua, et al.. (2025). Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation. Signal Transduction and Targeted Therapy. 10(1). 78–78. 12 indexed citations
3.
Du, Yuhui, Guoqing Wang, Bin Liu, et al.. (2024). Naringin alleviates fluoride-induced neurological impairment: A focus on the regulation of energy metabolism mediated by mitochondrial permeability transition pore. The Science of The Total Environment. 955. 177073–177073. 1 indexed citations
4.
Ta, Na, Shihao Zhang, Xinyu Zhu, et al.. (2024). Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set. Cancer Letters. 594. 216981–216981. 4 indexed citations
5.
6.
Wang, Jin, Jianhua Luo, Yuanyu Zhao, et al.. (2022). Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy. Frontiers in Immunology. 13. 863346–863346. 25 indexed citations
7.
Huang, Yuan, et al.. (2021). Concentrations of heavy metals in PM2.5 and health risk assessment around Chinese New Year in Dalian, China. Open Geosciences. 13(1). 1366–1374. 5 indexed citations
8.
Guo, Meng, Chen Sun, Liye Zhu, et al.. (2021). Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy. Frontiers in Oncology. 11. 632540–632540. 11 indexed citations
9.
Guo, Meng, Hailing Zhang, Jianming Zheng, & Yanfang Liu. (2020). Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma. Journal of Cancer. 11(8). 2008–2021. 121 indexed citations
10.
Song, Shaohua, Fang Liu, Yuanyu Zhao, et al.. (2020). Bruton’s Tyrosine Kinase Inhibitor Attenuates Warm Hepatic Ischemia/Reperfusion Injury via Modulation of the NLR Family Pyrin Domain Containing 3 Inflammasome. Transplantation Proceedings. 52(10). 2947–2954. 4 indexed citations
11.
Guo, Meng, Shu Han, Yanfang Liu, et al.. (2019). Inhibition of allogeneic islet graft rejection by VISTA-conjugated liposome. Biochemical and Biophysical Research Communications. 516(3). 914–920. 3 indexed citations
12.
Bao, Leilei, Dongke Zhang, Shu Han, et al.. (2018). MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID. Cellular Physiology and Biochemistry. 47(5). 2046–2055. 16 indexed citations
13.
Chen, Ziqi, Fang Liu, Nanxin Zheng, et al.. (2018). Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomedicine & Pharmacotherapy. 110. 285–293. 34 indexed citations
14.
Ma, Jinghui, et al.. (2017). Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-β promoter regions. Biochemical and Biophysical Research Communications. 493(2). 1122–1128. 62 indexed citations
15.
Meng, Jun, Xingguang Liu, Peng Zhang, et al.. (2016). Rb selectively inhibits innate IFN-β production by enhancing deacetylation of IFN-β promoter through HDAC1 and HDAC8. Journal of Autoimmunity. 73. 42–53. 32 indexed citations
16.
Liu, Yanfang, Xin Zhang, Yujing Zhang, et al.. (2015). Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Cancer Letters. 369(1). 58–66. 37 indexed citations
17.
Chen, Xiaohong, Xu Liu, Quanxing Wang, et al.. (2014). Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway. Experimental Cell Research. 330(1). 43–55. 30 indexed citations
18.
Gu, Jun, Xu Liu, Quanxing Wang, et al.. (2013). Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models. Journal of Molecular and Cellular Cardiology. 65. 1–8. 34 indexed citations
19.
Fu, Hailong, Huan Chen, Chengcai Wang, et al.. (2012). Flurbiprofen, a Cyclooxygenase Inhibitor, Protects Mice from Hepatic Ischemia/Reperfusion Injury by Inhibiting GSK-3β Signaling and Mitochondrial Permeability Transition. Molecular Medicine. 18(7). 1128–1135. 27 indexed citations
20.
Zhang, Xin, Shu Han, Meng Guo, et al.. (2012). SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection. Cellular and Molecular Immunology. 9(5). 390–398. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaoya Liu Breakdown of academic impact, for papers by Sen Wei Breakdown of academic impact, for papers by Fengwei Li Breakdown of academic impact, for papers by Elżbieta Urasińska Breakdown of academic impact, for papers by Jilin Li Breakdown of academic impact, for papers by Shunji Nakatsuji Breakdown of academic impact, for papers by Qun Zhang Breakdown of academic impact, for papers by Jianlin Chen Breakdown of academic impact, for papers by Bo Jin
Rankless by CCL
2026